The Board of MIA has appointed Maria Gonzalez as Chief Executive Officer following a comprehensive external search. Maria has led MIA as Interim CEO since December 2025. Read more about how Maria has been a senior leadership team member at MIA for sixteen years, helping build the organisation.
As published in The Australian, Prof Richard Scolyer AO’s friends and colleagues, Professor Georgina Long AO and Dr Kerry Crotty, share their reflections on Richard’s extraordinary spirit, his exceptional contributions to the fields of melanoma and pathology, and his lasting legacy.
Over the next three months, Prof Georgina Long will work with some of Europe's leading cancer research and treatment centres, advancing collaborative research in melanoma and neoadjuvant immunotherapy.
All of us at Melanoma Institute Australia (MIA) and the wider melanoma community are mourning the loss of our esteemed colleague and friend, Professor Richard Scolyer AO.
Prof Richard Scolyer AO has announced that he has decided to step down from his role as Co-Medical Director of Melanoma Institute Australia. Richard has been in this role since January 2017.
Pictures tell a thousand words, and we are proud to share this photo tribute of Kay and her friendship with us over many years.
It is with a heavy heart that we notify you that Kay Van Norton Poche AO, one of Melanoma Institute Australia's great friends and committed supporters, passed away on 14 June 2024, following a long illness.
This important initiative will enable all MIA employees identifying as female to further develop and accelerate their leadership skills training.
We are so proud of our MIA Co-Medical Directors, Prof Georgina Long AO and Prof Richard Scolyer AO, jointly named 2024 Australians of the Year.
Congratulations to MIA Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, jointly named 2024 NSW Australian of the Year.
